• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
PLoS ONE. 2008; 3(8): e3099.
Published online Aug 29, 2008. doi:  10.1371/journal.pone.0003099
PMCID: PMC2518122

Binomial Mitotic Segregation of MYCN-Carrying Double Minutes in Neuroblastoma Illustrates the Role of Randomness in Oncogene Amplification

Beth Sullivan, Editor



Amplification of the oncogene MYCN in double minutes (DMs) is a common finding in neuroblastoma (NB). Because DMs lack centromeric sequences it has been unclear how NB cells retain and amplify extrachromosomal MYCN copies during tumour development.

Principal Findings

We show that MYCN-carrying DMs in NB cells translocate from the nuclear interior to the periphery of the condensing chromatin at transition from interphase to prophase and are preferentially located adjacent to the telomere repeat sequences of the chromosomes throughout cell division. However, DM segregation was not affected by disruption of the telosome nucleoprotein complex and DMs readily migrated from human to murine chromatin in human/mouse cell hybrids, indicating that they do not bind to specific positional elements in human chromosomes. Scoring DM copy-numbers in ana/telophase cells revealed that DM segregation could be closely approximated by a binomial random distribution. Colony-forming assay demonstrated a strong growth-advantage for NB cells with high DM (MYCN) copy-numbers, compared to NB cells with lower copy-numbers. In fact, the overall distribution of DMs in growing NB cell populations could be readily reproduced by a mathematical model assuming binomial segregation at cell division combined with a proliferative advantage for cells with high DM copy-numbers.


Binomial segregation at cell division explains the high degree of MYCN copy-number variability in NB. Our findings also provide a proof-of-principle for oncogene amplification through creation of genetic diversity by random events followed by Darwinian selection.


Neuroblastomas (NB) are tumours of the sympathetic nervous system, occurring predominantly in early childhood and accounting for 8–10% of all paediatric cancers. One of the most important prognostic markers in NB is amplification of the oncogene MYCN, which is observed in ≈30% of NB [1]. Amplification of MYCN is associated with advanced stages of disease and the 3-year event-free survival of tumours with MYCN amplification is <20% [2]. The MYCN protein forms a heterodimer with MAX. This protein complex functions as a transcriptional activator, the targets of which include ODC, MCM7, and MDR1 [3], [4]. The activation of these genes leads to progression through the G1 phase of the cell cycle. Conversely, transcriptional repression of MYCN, or MYCN copy-number elimination, leads to growth-arrest, senescence and apoptosis of NB cells [5][7]. Cytogenetically, MYCN amplicons are typically carried either in extrachromosomal double minute (DMs) or in intrachromosomal homogeneously staining regions (HSRs). Under in vitro conditions HSR is the most common manifestation of MYCN amplification, whereas in fresh NB biopsies the amplicons are typically carried by DMs [8]. DMs are composed of circular DNA, up to only a few million base pairs in size, containing no centromere and no telomere [9]. DMs typically replicate only once during S-phase [10]. Because DMs lack centromeric sequences it has remained unclear how they segregate through mitosis and, consequently, how they are maintained and amplified in a growing NB cell population. However, recent elegant studies of the colorectal cancer model COLO322 have shown that DMs can move through mitosis by binding close to the termini of human chromosomes [11], [12]. The aims of the present study were (1) to characterise the cell cycle dynamics of DMs in NB cells and assess to which extent their behaviour is similar to that inferred by studies in other model systems, (2) to deduce the statistical principles of DM segregation, and (3) to investigate the topography of DM binding sites on human chromosomes. Based on our findings, we finally sought to assess whether unequal segregation of DMs to daughter cells at mitosis could play a mechanistic role in MYCN gene amplification by generating cell populations with heterogeneous DM copy-numbers on which Darwinian principles could be imposed.


Cell cycle dynamics of DMs

To locate DMs in relation to chromosomes through the cell cycle, MYCN amplicons in the two NB cell lines CHP-212 and SK-N-AS were detected by combined fluorescence in situ hybridization (FISH) and beta-tubulin immunofluorescence using epifluorescence microscopy (Figure 1A–F). As a comparison, we also analysed neuroepithelioma MC-IX cells carrying MYC amplification in DMs. In >85% of the analysed interphase cells (>1000 cells/cell line scored), DMs were distributed evenly in the nucleus. The remaining nuclei either exhibited DMs restricted to the nuclear periphery (10–14%) or a preferential localisation of DMs to nuclear membrane protrusions or micronuclei (<1%). In contrast, prometaphase and metaphase cells (>100 cells/cell line scored) invariably showed DMs only at the periphery of the prometaphase rosette/metaphase plate. At anaphase, the DMs in all three cell lines remained at the periphery of the chromosome poles and were typically (>90% of DMs) located at, or adjacent to, the termini of the chromosomes (>50 cells/cell line scored). This configuration was also observed in telophase cells. DMs that had detached from the chromosomes were not included in the analyses; these consisted of <10% of observed DMs.

Figure 1
Fluorescence microscopy.

In order to characterize the mitotic distribution of DMs during the cell cycle in three dimensions, we then performed confocal microscopy of mitotic and interphase cells in the three cell lines (>20 mitotic cells and >10 interphase cells scored in each line). DMs were classified as peripherally located if the corresponding FISH signals overlapped with the chromatin border as assessed by DRAQ5 counterstaining (Figs. 1G–K). From prometaphase through telophase, 100% of DMs were located peripherally, close to the chromosome termini. In contrast, <20% of DMs in interphase cells located peripherally, while the remaining DMs were distributed at locations not overlapping with the outer chromatin border. This fluctuation in distribution between interphase and mitosis was observed in all the cell lines, without any significant difference between them in the fraction peripheral DMs at interphase or mitosis.

The mitotic location of DMs adjacent to chromosome termini prompted us to investigate whether DMs co-localized with telomeric repeat sequences in LA-N-5 and CHP-212. Co-hybridization with MYCN and TTAGGG-sequence probes assessed by epifluorescence microscopy showed that approximately 80% of MYCN signals overlapped with signals from telomeric repeats in mitotic cells from prometaphase through telophase (Figure 1L–N). In contrast, <10% of MYCN signals in interphase nuclei typically overlapped with TTAGGG repeat signals. As a comparison, co-hybridization with MYCN and pan-centromeric (alpha-satellite sequence) probes was also performed in LA-N-5 and CHP-212. On average, only 4% and 6% of MYCN signals, respectively, overlapped with centromere signals in mitotic cells and interphase cells (range 0–13% and 0–16%, respectively; 60 cells analyzed per cell line).

To validate our fluorescence microscopy data by an additional method, we performed further analysis of DM topography in mitotic CHP-212 cells by combined atomic force microscopy (AFM) and FISH. AFM is a well established technique in material sciences, making it possible to map surface topography with nanometre resolution. Superimposition of FISH images and AFM topography plots made it possible to establish the location of single and clustered DMs with high precision in three dimensions and confirmed the peripheral localisation of DMs at mitosis (Figure 2). Approximately half of the totally 50 DMs analysed were located on the surface of chromosomes, corresponding to peaks of approximately 200 nm in the AFM surface plots. The other DMs were located in grooves between chromosomes. In interphase cells, there was no clear correlation between DMs and surface features by AFM (data not shown). Taken together, our FISH and AFM data thus indicated that DMs underwent repeated topographical fluctuations during the cell cycle, moving rapidly from locations in the nuclear interior at interphase to positions adjacent to the telomeres at prometaphase, where they remained through telophase to finally drift back into the interior of the newly formed interphase nucleus.

Figure 2
Atomic force microscopy.

Statistical distribution of DMs at mitosis

We then attempted to assess the statistical distribution of DMs between daughter cells by scoring the DM copy-numbers in opposite ana-telophase poles. To evaluate whether scoring by two-dimensional microscopic analysis was a sufficiently precise method for this, we first scored DMs, detected by MYCN or MYC probes, in 30 interphase cells from each of CHP-212, LA-N-5, and MC-IX, both by serial confocal sections (3D; 1 AU pinhole) and a single wide confocal section (2D; >5 AU pinhole). The average difference in DM copy number per cell by 2D analysis compared to 3D analysis was very low in each cell line up to a copy-number of approximately 100 (3.4–3.9% of the total DM copy-number; Figure 3A–C). Based on this, we then scored DM copy-number by epifluorescence microscopy in ana- and telophase cells, identified by cross-labelling with beta-tubulin (Figure 3D; 100 cells scored in CHP-212, 100 in LA-N-5, and 50 in MC-IX). Plotting of copy-number data revealed a similar pattern in the three cell lines. An identical DM copy-number in two opposite daughter poles was very rare, but the interpolar differences in copy number were typically small and there was a positive correlation in copy-number between opposite poles (r = 0.53 in LA-N-5, r = 0.92 in CHP-212, r = 0.94 in MC-IX; p<0.05 for all). Our data could readily be approximated by assuming binomial distribution of DMs at mitosis, with a probability of 50% for an individual DM to segregate into each daughter cell (Figure 3E–F). In CHP-212 and MC-IX only 2% of cell divisions deviated significantly (P<0.01) from such a binomial distribution, whereas in LA-N-5, 10% deviated from this distribution.

Figure 3
Statistics of DM segregation.

To assess whether the rare mitoses with a non-binomial DM segregation pattern were reflected by corresponding copy-number heterogeneity in growing cell populations, single cells were then isolated from each cell line and expanded to monoclonal colonies, in which DM copy-numbers were scored in individual cells by interphase-FISH. In total, 20 colonies from each cell line were analysed. With few exceptions, the colonies showed modal DM copy-numbers similar to those of the original cultures. In order not to overestimate the number of cells with copy-numbers produced by a non-binomial distribution, cells that deviated in >20 DM copies from each clone's modal value (outlier cells) were tested against a hypothetical binomial segregation, using the cell with the DM copy-number closest to its own as its presumed post-mitotic sister cell. It has been shown that DMs separate into single minutes during G1-phase [15] and it could therefore not be excluded that outlier cells with higher copy-numbers than a specific colony's modal value represented cells where the DMs had just separated into single-minutes, leading to a duplication of the actual DM copy-numbers. Therefore, only outlier cells with copy-numbers below each colony's modal copy-number were tested. Using this approach, cells with copy-numbers not consistent with binomial segregation were found in 2–6 monoclonal colonies from each cell line (Supplementary Figure S1). Using the total number of cells in each colony to calculate the minimum number of cell divisions that occurred during colony-formation, the frequency of non-binomial DM segregations were approximately 3% (3/88) in CHP-212, 2% (2/100) in MC-IX, and 8% (6/73) in LA-N-5. These values were consistent with the data from direct analysis of ana- and telophase cells, also showing a higher frequency of non-binomial segregation in LA-N-5 (10%) compared to CHP-212 (2%) and MC-IX (2%). Hence, even though non-binomial distributions were rare in the three cell lines, they were sufficiently frequent to generate cells with a DM copy-number strongly deviating from the modal value of the cell population.

Non-binomial distribution occurs through clustering at high DM copy numbers

One potential explanation of non-binomial DM segregation is detachment of multiple DMs at anaphase, leading to a decreased number of DMs in one of the daughter cells. Further image analysis of the ana- and telophase cells with non-binomial segregation showed that these cells rarely exhibited DMs that detached from the chromosomes, and no more than 4 DMs were observed to be detached in any single cell. This argued against loss of DMs through micronucleus formation as a mechanism for non-binomial segregation. However, the ana- and telophase cells with a non-binomial DM distribution had a higher median DM copy-number than those with a binomial distribution (median 74 vs. 40; P<0.0001 Mann-Whitney test; two-sided; pooled data from the three cell lines). Based on this, we selected 10 ana-telophases with a DM copy-number >50 from each cell line for a detailed analysis by confocal microscopy. This showed that all of the totally 30 analyzed ana-telophases exhibited at least one cluster of DMs at or adjacent to the chromosome termini (Figure 4A and B). The precise number of DMs in each cluster could not be determined at the obtained resolution level, but each cluster appeared to contain at least 5 DMs. In contrast, only approximately one third of ana-telophase cells with 50 or fewer DMs contained clusters, typically containing only two or three DMs.

Figure 4
Clustering of DM at high copy-number.

Previous studies have shown that gamma radiation exposure induces clustering of DMs as well as elimination of DMs through micronucleation [16]. To evaluate whether non-binomial DM distribution could be promoted by radiation-induced clustering of DMs, we subjected CHP-212 cells to ionising radiation (2 Gy and 4 Gy) prior to MYCN FISH detection in ana-and telophase cells. Analysis of the DMs that remained attached to chromosomes, often arranged in clusters, indeed showed an elevated frequency of segregations deviating (P<0.01) from the binomial distribution compared to unexposed cells, 2% after 0 Gy, 22% after 2 Gy and 24% after 4 Gy (Figure 4C). Although copy-number estimation could be expected to be more error-prone in these mitoses, with many clustered DMs, our collected data thus indicated that clustering of DMs could be one cause of deviations from the binomial distribution at high DM copy-numbers.

DM frequency distributions can be modelled by selection imposed on the binomial distribution

Early studies of DMs in tumour bulk populations by chromosome banding have indicated that their overall copy-number distribution conforms neither to a binomial nor to a Poisson distribution [14]. Assessment of the DM copy-number distribution in metaphase spreads by FISH in CHP-212, LA-N-5, MC-IX and in primary cultures from two fresh neuroblastoma samples revealed a skewed non-binomial (P<0.01; Chi Square test) distribution in all samples, with a tail towards higher copy-numbers (Figure 5A and Supplementary Figure S2). These findings were similar to the distribution previously described in the SEWA-model [14], suggesting a uniform principle behind DM frequency distribution in different cell systems.

Figure 5
DM copy-number distributions in bulk populations.

It has been well established that a high MYCN-copy number corresponds to elevated levels of MYCN expression [17][19], which in turn results in increased cellular proliferation [2], [20][22]. Accordingly, when a colony formation assay was performed for CHP-212, the MYCN copy-number by interphase FISH was found to be significantly higher in colony-forming than in single cells (Figure 5B; >20 colonies and >100 single cells evaluated). Thus, proliferative advantages existed, at least in vitro, for cells with a high number of DMs, compared to those with a low number. On the other hand, cells with very high (>200 DMs) were extremely rare in our model systems, indicating some degree of selection against cells with an extremely high DM copy-number. Based on this, we hypothesized that cells with a higher DM copy-number would divide more frequently up to a certain copy-number level, where the selection pressure would continuously shift to become less favourable (Figure 6A). A simple algorithm applying these criteria on a model in which DMs segregated in a binomial fashion at mitosis reproduced the skewed frequency distribution observed in our cell lines and tumour biopsies when clonal growth from a single cell containing one DM was simulated (Figure 6B–C). Thus, a very simple model of Darwinian selection superimposed on binomial distribution of DMs at cell division was capable of explaining the frequency distribution of DMs, including a minority cell population with high MYCN copy numbers.

Figure 6
Mathematical modelling.

DMs are not irreversibly bound to positionally stable chromosome elements

Since DMs were localized very close to telomeres during mitosis, we investigated to what extent the mitotic segregation of DMs was dependent on telomere stability. Neuroblastoma cell lines invariably express telomerase [23], which is believed to be crucial for stabilizing telomere length in transformed cells [24], [25]. To shorten telomeres to a critical length and disrupt telosome function, we treated CHP-212 cells for 14 days with the telomerase inhibitor MST-312 [26], [27]. MST-312 has been shown to inhibit telomerase activity by 47–66% in our culture system [28]. As expected, MST-312 treatment resulted in a significant shortening of telomeres as determined by quantitative FISH with peptide nucleic acid probes against TTAGGG-repeats (Figure 7A). Increased frequencies of chromosome termini without detectable TTAGGG-sequences were also observed, corresponding to critically short, potentially unstable telomeres (Figure 7B–D). Accordingly, MST-312 treated cells showed an elevated frequency of anaphase bridges compared to untreated CHP-212 cells (Figure 7E–F), indicating that telomere shortening induced global chromosomal instability in this cell line. However, when MYCN-FISH was performed on MST-312 treated ana-telophase cells, there was no difference in the number of cells deviating from a binomial distribution of DMs (Figure 7G), nor was there an increase in the frequency of DMs that had detached from the chromosomes (one detached DM each in 2/50 cells after MST-312 treatment). Thus, DM segregation did not seem dependent on binding to functional telomeres in human chromosomes.

Figure 7
DMs do not bind to telomeres or other specific positional elements.

To further assess whether DMs were bound to any other positionally stable structures on human chromosomes, we used cell fusion by polyethylene glycol to create NB/mouse (CHP-212/3T3) hybrid nuclei. Human- and mouse- specific repetitive DNA sequences and MYCN-carrying DMs were then detected by triple colour FISH in these hybrid cells. Hybrid nuclei were obtained in approximately 1[ratio]60 cells. In all the 50 analysed hybrid nuclei, murine and human chromosome domains could be readily distinguished by our FISH strategy (Figure 7H). In these nuclei, 36–76% of DMs were located in murine chromosome domains and there was no difference in the number of DMs located in human domains compared to mouse domains (Figure 7I). In the few mitotic hybrid cells that were observed, DMs attached both to murine and human chromosomes (Figure 7J). Thus, DMs were free to relocate to murine chromosome domains in interspecies hybrid nuclei, indicating that they do not bind irreversibly to a specific positional element on human chromosomes.


MYCN amplification is the strongest biological predictor of outcome in NB patients [1]. It has previously been shown that MYCN copy-numbers can be highly heterogeneous in NB cell populations. Such genetic heterogeneity may reflect different tumour clones and its role is believed to be under-recognized and underestimated in neuroblastoma biology [29]. In spite of this, the mechanisms behind clonal variability have been little investigated in NB cells. It is known from earlier studies that the DMs typically carrying MYCN copies in vivo do not separate at anaphase, but remain as double circles until G1-phase [14], [15], [30]. Evidently, a random distribution of DMs at the metaphase-anaphase transition would readily explain clonal variability [18], but whether the events governing DM distribution to daughter cells are really random had not previously been tested experimentally. Furthermore, the randomness function best approximating the behaviour of DMs had not been determined.

In the present study, we show that DMs in NB cells exhibit a regular topographic fluctuation during the cell cycle, translocating rapidly from the nuclear interior to the periphery of the prometaphase rosette at the initiation of cell division, attaching close to the telomeric repeat sequences. For the vast majority of DMs, this attachment was retained from prometaphase through telophase. After reconstitution of the interphase chromatin structure, the DMs relocated to the nuclear interior, possibly to occupy positions at the periphery of chromosome territories [18], separate to single minutes during G1-phase [15], and replicate in S-phase [30] as described. Our findings are highly consistent with previous descriptions of DM behaviour in non-NB model systems, including the human COLO322 [12], [31] and the murine SEWA cell lines [14]. Thus our description of the mitotic topography of DMs mainly serves to confirm that previously suggested models of DM behaviour at cell division are applicable to NB. In contrast, our findings regarding the statistical distribution of DMs are novel and confirm a long held suspicion of the origin of oncogene copy-number heterogeneity.

We showed that the skewed frequency distributions of DM copy-number could be modelled by combining binomial mitotic segregation with a selection pressure favouring cells with a higher DM copy-number up to a certain level. The binomial distribution is the discrete probability distribution of the numbers in a sequence of n independent events, each of which yields one out of two possible outcomes with the probability p. In the context of DM segregation, n corresponds to the DM copy-number at metaphase. Because we assumed that each DM was equally likely to segregate to one of the daughter cells as to the other, p was set to 0.5. Our finding that DM copy-numbers can be described by a simple binomial distribution has at least three implications for the evolution of MYCN amplicons in NB cells: (1) MYCN-copies in DMs segregate independently of each other in a random fashion up to a certain copy-number level. (2) When this level has been reached, the random binomial model is no longer applicable; our experimental data indicate that this level is determined by the copy-number at which DMs start to interact with each other to form clusters, presumably because of the spatial restrictions of the mitotic figures. (3) The modal DM copy-number in the tumour cell population reflects the number of MYCN-copies conferring the greatest proliferative advantage under these cells' specific growth conditions. In the established cell lines and tumours used in the present study, this number varied between 25 and 50 DMs.

We cannot completely exclude that non-binomial segregation of clustered DMs also has a role in generating the skewed frequency distribution found in tumour bulk populations. However, non-binomial segregations were relatively rare in our material. Furthermore, they would be more likely to generate discrete sub-populations at non-modal copy-numbers rather than a continuous, skewed distribution. Our findings do not unequivocally explain the negative selection pressure at higher DM copy-numbers, although it points to clustering as a cause of non-binomial segregation at high copy-numbers. Such mitotic clustering should cause dramatic shifts in MYCN-copy number after cell division, potentially leading to dysregulation of MYCN-dependent intracellular signalling systems and apoptosis [32]. Nevertheless, our mathematical model is supported by several studies showing that MYCN amplification confers a proliferative advantage [5], [33][35], and also by our own finding of a higher DM copy number among colony-forming CHP-212 cells compared to non-colony forming cells.

Our findings do not explain the molecular mechanisms underlying the topographical fluctuation of DMs during the cell cycle. The co-localisation of DMs and telomeric TTAGGG-repeats at mitosis could suggest that DMs bind to parts of the telosome multiprotein complex. However, disruption of telomere stability by telomere shortening induced by MST-312 failed to perturb the binomial segregation of DMs at cell division. Even though our studies do not fully exclude that DMs bound to the telomeres that remained intact after telomerase inhibition, our data speak against a specific interaction between DMs and the telosome complex. This was further supported by the finding that not all DMs co-localised with telomere repeats at cell division and also by our confocal microscopy and AFM images showing that several DMs were localised to interstitial segments close to the termini, rather than to the termini per se. A previous study has demonstrated that DMs are typically located at the periphery of folded chromosome territories in interphase nuclei [18]. It is possible that the centripetal force acting on centromeres during formation of the prometaphase rosette results in a centrifugal movement of DMs relative to the chromosomes as DMs do not interact with the mitotic spindle. The peripheral translocation of DMs at prometaphase formation would then be caused by DMs sliding longitudinally along the chromosomes as the interphase chromosome territories condense at prometaphase and are pulled centrally by the spindle fibres. Our findings are consistent with those of a previous study, based on the COLO322 cell line, showing that DMs were repelled from the spindle poles while they attached to the chromosome periphery [11]. Disrupting microtubule organization eliminated such peripheral localization of DMs in this model system, but it did not affect their association with chromosomes, indicating that a microtubule-mediated antipolar force would be responsible for the mitotic fluctuation of DMs. Together with our data, these findings imply that unspecific, weak biophysical forces cause the attachment of DMs to chromosomes during mitosis. This is supported by our finding that DMs could move freely in the interphase nuclei of interspecies hybrids.

The present study is one of a few showing a specific mechanism causing genetic heterogeneity by random events, which in turn can form the substrate for selection according to Darwinian principles, ultimately leading up to oncogene amplification and an increased proliferation of tumour cells. Furthermore, by clarifying the statistical principles of MYCN amplicon segregation, we have now acquired a precise standard against which the effects of potential anti-neuroblastoma drugs acting through MYCN amplicon elimination can be compared. The mechanisms by which DMs bind to chromosomes in NB clearly need to be studied further, particularly as the molecules participating in this attachment would be attractive therapeutic targets. If the binding of DMs to chromosomes could be efficiently, and specifically, inhibited, this could be an efficient way of eliminating MYCN amplicons from NB cells, thus causing growth reduction and apoptosis [5][7]. The present study may provide a first step in identifying target proteins for such drugs, implicating weak biophysical forces rather then covalent attachments and binding to broadly distributed chromosome bio-molecules rather than specific binding to the telosome nucleoprotein complex.

Materials and Methods

Cell lines and cell culture

The study was reviewed and approved by the Ethics Review Board at Lund University Hospital, Sweden. The NB cell-lines CHP-212 and LA-N-5, the neuroepithelioma cell-line MC-IX, and mouse 3T3 cells were obtained from the American Type Culture Collection. Chromosome preparations from NB tumour biopsies and bone marrow infiltrates were obtained from the Department of Clinical Genetics in Lund. Cell culturing, harvest and chromosome preparation for FISH were according to standard methods [36]. All cells were cultured in DMEM[ratio]F12 1[ratio]1 supplemented with 10% foetal bovine serum and antibiotics. Single-cell clones were made from trypsinized single cell suspensions and plated in collagen- and fibronectin-coated chamber slides (5,000–10,000 cells/slide). Attaching cells were cultured for two weeks under standard conditions. The analysis was limited to colonies with a circular growth pattern, growing separate from other colonies, in order to avoid scoring colonies originating from different cells. Cell lines subjected to ionizing radiation were harvested for analysis 5–10 after irradiation, when mitotic figures were first visible by microscopic inspection.

FISH analysis

DMs were detected by single-copy probes for MYCN and MYC (Abbott Molecular Inc., Des Plaines, IL) and telomeric repeat sequences by fluorescein-conjugated (CCCTAA)3 peptide nucleic acid probes as described [37]. Human and murine DNA sequences were identified by hybridisation with Cy3-labelled mouse Cot-1 and biotin-Cy5-labelled human Cot-1, respectively (Invitrogen, Stockholm, Sweden). The number of DMs was calculated manually in digital images acquired by a CCD camera coupled to an epi-fluorescence microscope. For combined immunofluoroscence and FISH, cells were fixed in −20°C methanol for 5–10 minutes and air-dried. Slides were then rehydrated in PBS containing 1% bovine serum albumin (BSA) for at least 30 min. Beta-tubulin was detected by the monoclonal antibody TUB2.1 (Sigma-Aldrich, St. Louis, MO), conjugated to Cy3, diluted 1[ratio]100 in 1% BSA/PBS and incubated with the target cells for 60 min at room temperature. After incubation, target cells were washed twice in 1% BSA/PBS and antibody conjugation was fixed by immersion in 1% formaldehyde for 5 min. After washing in PBS and dehydration in ethanol, FISH was performed by standard protocols without prior enzymatic pre-treatment.

Confocal microscopy

Cells were fixed according to Solovei et al. [18]. Confocal images were obtained on a Zeiss LSM 510 META system with an inverted Zeiss Axiovert 100 M microscope and LSM 510 META software version 3.2 (Carl Zeiss, Jena, Germany). FITC was excited with the 488 nm line of a krypton-argon laser and emission was collected through a Plan-Fluar 100x/1.45 NA objective using a band-pass 505–550 nm filter. DRAQ5-labelled chromatin (Biostatus Ltd, Shepshed, UK) was excited by the 633 nm line of a helium-neon laser and emission was collected using a band-pass 644.5–719.4 filter. The pinhole was adjusted to 1 AU (Airy units) when acquiring confocal images and set to 5 AU or above for two-dimensional images.

Combined AFM and FISH

Combined AFM and optical microscopy investigations were performed using a JPK Nanowizard II AFM with the JPK Life Science stage mounted on an inverted optical microscope (Nikon TE2000-U; JPK Instruments AG, Berlin, Germany). For all measurements, a Nikon CFI Plan Apo VC 60x, 1.40 DIC oil immersion objective was used. For epi-fluorescence a mercury light source was used in combination with standard filter blocks: DAPI (Ex 340-380nm, DM 400nm, BA 435-485nm), TRITC (Ex 540/25nm, DM 505nm, Em 605/55nm). A standard CCD camera was used for the digital imaging acquisition. Prior to AFM imaging, the samples were inspected by phase contrast microscopy to locate the regions of interest as well as for precise location of the AFM tip. The cantilever was placed above the selected region using the positioning screws on the stage before approaching the tip to the sample surface. For AFM imaging, standard noncontact cantilevers were used in intermittent contact mode to reduce the lateral forces during scanning. The scan speeds were typically 0.3–0.5 Hz when acquiring images with 512×512 pixels. AFM and FISH images were superimposed using AdobePhotoshop.

Interspecies cell hybrids

Cytoplasmic membrane fusion was achieved in sub-confluent cultures containing CHP-212 and 3T3 cells at equal proportions by washing in serum-free medium, followed by treatment with 50% polyethylene glycol (PEG 6000, BDH Chemicals Ltd., Poole, UK) for 2 min. PEG-treated cells and untreated control cultures were then grown in DMEM[ratio]F12 1[ratio]1 supplemented with 10% foetal bovine serum and antibiotics for 3–4 days before harvest.

Telomerase inhibition

The MST-312 telomerase inhibitor (Calbiochem/EMD Biosciences, Madison, WI) was diluted in DMSO and used at a noncytotoxic concentration of 1.0 µmol/L (25). To maintain a stable concentration of MST-312, the medium was changed every third day. Cultures exposed only to DMSO were cultured in parallel as controls. Colony formation assay was done by plating 10 000 cells on chamber slides. The rate of population doubling was measured by colony formation assay at regular intervals with colonies defined as groups of >10 cells.

Mathematical modelling

The time between divisions for a cell with n DMs was set to 1+10/(1+n)+n^2/10000, where the term 1 was the lower limit of the inter-mitotic time, and the term 10/(1+n) simulated the growth advantage of cells with high DM copy-numbers. 1/(n+1) was used instead of 1/n so that cells with 0 DMs would obtain a finite time to the next division. The term n^2/10000 was used to simulate a penalty on cells with very high DM counts. After each mitotic cycle, the n for each cell was doubled and then distributed randomly according to a binomial function between the two daughter cells. To keep computations limited we capped the cell population at 100,000 by random deletion. Each simulation was initiated with a single cell starting with a DM count equal to 1 at time zero. Matlab (MathWorks, Kista, Sweden) programming was used to simulate the growth of each population according to these rules.

Supporting Information

Figure S1

Single cell colonies. DM interphase copy-number distributions in single-cell-derived colonies from LA-N-5, CHP-212, and MC-IX. Scored interphase nuclei correspond to red and grey circles, respectively, of which only the former were included in the statistical analysis (see text). Variations in DM copy-number that were not explained (P<0.01) by a binomial distribution are marked by arrows.

(0.57 MB TIF)

Figure S2

DM copy-numbers. The DM frequency distribution in near-diploid metaphase cells in the CHP-212 and MC-IX cell lines, and in biopsies from one primary NB (Patient 1), and one bone marrow NB metastasis (Patient 2). Similar to SK-N-5, the distributions are skewed towards higher copy-numbers and differ from a normal distribution (P<0.01; Chi Square Test).

(0.10 MB TIF)


Competing Interests: The authors have declared that no competing interests exist.

Funding: This study was supported by the Swedish Children's Cancer Foundation, the Swedish Cancer Society, the Swedish Research Council, the Swedish Medical Society, the Lund University Hospital Donation Funds, the Gunnar Nilsson Cancer Foundation, the Crafoord Foundation, the Erik-Philip Sörensen Foundation, the Lundgren Foundation, and the Medical Faculty at Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.


1. Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, et al. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313:1111–1116. [PubMed]
2. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203–216. [PubMed]
3. Norris MD, Bordow SB, Haber PS, Marshall GM, Kavallaris M, et al. Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma. Eur J Cancer. 1997;33:1911–1916. [PubMed]
4. Shohet JM, Hicks MJ, Plon SE, Burlingame SM, Stuart S, et al. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma. Cancer Res. 2002;62:1123–1128. [PubMed]
5. Narath R, Ambros IM, Kowalska A, Bozsaky E, Boukamp P, et al. Induction of senescence in MYCN amplified neuroblastoma cell lines by hydroxyurea. Genes Chromosomes Cancer. 2007;46:130–142. [PubMed]
6. Tonelli R, Purgato S, Camerin C, Fronza R, Bologna F, et al. Anti-gene peptide nucleic acid specifically inhibits MYCN expression in human neuroblastoma cells leading to cell growth inhibition and apoptosis. Mol Cancer Ther. 2005;4:779–786. [PubMed]
7. Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, et al. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Clin Cancer Res. 2005;11:4321–4330. [PubMed]
8. Moreau LA, McGrady P, London WB, Shimada H, Cohn SL, et al. Does MYCN amplification manifested as homogeneously staining regions at diagnosis predict a worse outcome in children with neuroblastoma? A Children's Oncology Group study. Clin Cancer Res. 2006;12:5693–5697. [PubMed]
9. Barker PE. Double minutes in human tumor cells. Cancer Genet Cytogenet. 1982;5:81–94. [PubMed]
10. Barker PE, Drwinga HL, Hittelman WN, Maddox AM. Double minutes replicate once during S phase of the cell cycle. Exp Cell Res. 1980;130:353–360. [PubMed]
11. Kanda T, Otter M, Wahl GM. Mitotic segregation of viral and cellular acentric extrachromosomal molecules by chromosome tethering. J Cell Sci. 2001;114:49–58. [PubMed]
12. Kanda T, Wahl GM. The dynamics of acentric chromosomes in cancer cells revealed by GFP-based chromosome labeling strategies. J Cell Biochem Suppl. 2000;Suppl 35:107–114. [PubMed]
13. Levan A, Levan G. Have double minutes functioning centromeres? Hereditas. 1978;88:81–92. [PubMed]
14. Levan G, Mandahl N, Bregula U, Klein G, Levan A. Double minute chromosomes are not centromeric regions of the host chromosomes. Hereditas. 1976;83:83–90. [PubMed]
15. Deng X, Zhang L, Zhang Y, Yan Y, Xu Z, et al. Double minute chromosomes in mouse methotrexate-resistant cells studied by atomic force microscopy. Biochem Biophys Res Commun. 2006;346:1228–1233. [PubMed]
16. Schoenlein PV, Barrett JT, Kulharya A, Dohn MR, Sanchez A, et al. Radiation therapy depletes extrachromosomally amplified drug resistance genes and oncogenes from tumor cells via micronuclear capture of episomes and double minute chromosomes. Int J Radiat Oncol Biol Phys. 2003;55:1051–1065. [PubMed]
17. Schneiderman J, London WB, Brodeur GM, Castleberry RP, Look AT, et al. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group. J Clin Oncol. 2008;26:913–918. [PubMed]
18. Solovei I, Kienle D, Little G, Eils R, Savelyeva L, et al. Topology of double minutes (dmins) and homogeneously staining regions (HSRs) in nuclei of human neuroblastoma cell lines. Genes Chromosomes Cancer. 2000;29:297–308. [PubMed]
19. Stock C, Bozsaky E, Watzinger F, Poetschger U, Orel L, et al. Genes proximal and distal to MYCN are highly expressed in human neuroblastoma as visualized by comparative expressed sequence hybridization. Am J Pathol. 2008;172:203–214. [PMC free article] [PubMed]
20. Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224:1121–1124. [PubMed]
21. Stallings RL. Origin and functional significance of large-scale chromosomal imbalances in neuroblastoma. Cytogenet Genome Res. 2007;118:110–115. [PubMed]
22. Tsuda T, Obara M, Hirano H, Gotoh S, Kubomura S, et al. Analysis of N-myc amplification in relation to disease stage and histologic types in human neuroblastomas. Cancer. 1987;60:820–826. [PubMed]
23. Choi LM, Kim NW, Zuo JJ, Gerbing R, Stram D, et al. Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma. Med Pediatr Oncol. 2000;35:647–650. [PubMed]
24. Oshimura M, Barrett JC. Multiple pathways to cellular senescence: role of telomerase repressors. Eur J Cancer. 1997;33:710–715. [PubMed]
25. Smith LL, Coller HA, Roberts JM. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat Cell Biol. 2003;5:474–479. [PubMed]
26. Seimiya H, Oh-hara T, Suzuki T, Naasani I, Shimazaki T, et al. Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. Mol Cancer Ther. 2002;1:657–665. [PubMed]
27. Seimiya H, Sawada H, Muramatsu Y, Shimizu M, Ohko K, et al. Involvement of 14-3-3 proteins in nuclear localization of telomerase. EMBO J. 2000;19:2652–2661. [PMC free article] [PubMed]
28. Jin Y, Stewenius Y, Lindgren D, Frigyesi A, Calcagnile O, et al. Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers. Clin Cancer Res. 2007;13:1703–1712. [PubMed]
29. Thorner PS, Ho M, Chilton-MacNeill S, Zielenska M. Use of chromogenic in situ hybridization to identify MYCN gene copy number in neuroblastoma using routine tissue sections. Am J Surg Pathol. 2006;30:635–642. [PubMed]
30. Itoh N, Shimizu N. DNA replication-dependent intranuclear relocation of double minute chromatin. J Cell Sci. 1998;111(Pt 22):3275–3285. [PubMed]
31. Kanda T, Sullivan KF, Wahl GM. Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr Biol. 1998;8:377–385. [PubMed]
32. Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, et al. The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer Res. 2006;66:2826–2833. [PubMed]
33. del Carmen Mejia M, Navarro S, Pellin A, Ruiz A, Castel V, et al. Study of proliferation and apoptosis in neuroblastoma. Their relation with other prognostic factors. Arch Med Res. 2002;33:466–472. [PubMed]
34. Paffhausen T, Schwab M, Westermann F. Targeted MYCN expression affects cytotoxic potential of chemotherapeutic drugs in neuroblastoma cells. Cancer Lett. 2007;250:17–24. [PubMed]
35. Schweigerer L, Breit S, Wenzel A, Tsunamoto K, Ludwig R, et al. Augmented MYCN expression advances the malignant phenotype of human neuroblastoma cells: evidence for induction of autocrine growth factor activity. Cancer Res. 1990;50:4411–4416. [PubMed]
36. Gisselsson D. Refined characterisation of chromosome aberrations in tumours by multicolour banding and electronic mapping resources. Methods Cell Sci. 2001;23:23–28. [PubMed]
37. Lansdorp PM, Verwoerd NP, van de Rijke FM, Dragowska V, Little MT, et al. Heterogeneity in telomere length of human chromosomes. Hum Mol Genet. 1996;5:685–691. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science
PubReader format: click here to try


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...